[go: up one dir, main page]

WO2010024594A3 - Composition for preventing or relieving obesity or diabetes - Google Patents

Composition for preventing or relieving obesity or diabetes Download PDF

Info

Publication number
WO2010024594A3
WO2010024594A3 PCT/KR2009/004775 KR2009004775W WO2010024594A3 WO 2010024594 A3 WO2010024594 A3 WO 2010024594A3 KR 2009004775 W KR2009004775 W KR 2009004775W WO 2010024594 A3 WO2010024594 A3 WO 2010024594A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
diabetes
preventing
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/004775
Other languages
French (fr)
Korean (ko)
Other versions
WO2010024594A2 (en
Inventor
김민선
이진희
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ CheilJedang Corp filed Critical CJ CheilJedang Corp
Publication of WO2010024594A2 publication Critical patent/WO2010024594A2/en
Publication of WO2010024594A3 publication Critical patent/WO2010024594A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides a composition for preventing or relieving obesity or diabetes, and medicines or health foods containing the composition. The composition comprises 75-85 parts by weight of Garcinia cambogia extract, 15-25 parts by weight of soy peptides, and 0.5-5 parts by weight of L-carnitine.
PCT/KR2009/004775 2008-08-27 2009-08-27 Composition for preventing or relieving obesity or diabetes Ceased WO2010024594A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0084007 2008-08-27
KR1020080084007A KR20100025299A (en) 2008-08-27 2008-08-27 Composition for preventing or improving obesity or diabetes

Publications (2)

Publication Number Publication Date
WO2010024594A2 WO2010024594A2 (en) 2010-03-04
WO2010024594A3 true WO2010024594A3 (en) 2010-06-24

Family

ID=41722116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/004775 Ceased WO2010024594A2 (en) 2008-08-27 2009-08-27 Composition for preventing or relieving obesity or diabetes

Country Status (2)

Country Link
KR (1) KR20100025299A (en)
WO (1) WO2010024594A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2968462B1 (en) 2010-12-06 2013-06-07 Michelin Soc Tech DEVICE FOR GENERATING ELECTRICITY BY FUEL CELL.
KR20250042478A (en) 2023-09-20 2025-03-27 바이오모아메디칼 주식회사 Composition for reducing blood sugar, body fat or visceral fat
CN118077902B (en) * 2024-03-26 2024-07-26 哈尔滨粮投科创有限公司 Weight-losing composition containing probiotics and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084885A1 (en) * 2003-03-25 2004-10-07 Amorepacific Corporation Compositions for the improvement of obesity
KR20050064127A (en) * 2003-12-23 2005-06-29 주식회사 태평양 Compositions of slimming food containing dietary fiber for the treatment of obesity
KR20050112942A (en) * 2004-05-28 2005-12-01 주식회사 뉴트렉스테크놀러지 Composition for obesity suppression
WO2008054059A1 (en) * 2006-10-31 2008-05-08 Amorepacific Corporation Use for treating obesity and diabetes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084885A1 (en) * 2003-03-25 2004-10-07 Amorepacific Corporation Compositions for the improvement of obesity
KR20050064127A (en) * 2003-12-23 2005-06-29 주식회사 태평양 Compositions of slimming food containing dietary fiber for the treatment of obesity
KR20050112942A (en) * 2004-05-28 2005-12-01 주식회사 뉴트렉스테크놀러지 Composition for obesity suppression
WO2008054059A1 (en) * 2006-10-31 2008-05-08 Amorepacific Corporation Use for treating obesity and diabetes

Also Published As

Publication number Publication date
KR20100025299A (en) 2010-03-09
WO2010024594A2 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
WO2007104789A3 (en) Amylin derivatives
EP2133091A3 (en) Compositions comprising supramolecular insulin assemblies useful for the treatment of diabetes
WO2011003822A3 (en) Aqueous insulin preparations containing methionine
CL2007001006A1 (en) COMPOUNDS DERIVED FROM PIPERIDINE U 8-AZA-BICICLO [3.2.1] OCTANO SUBSTITUTED; PHARMACEUTICAL FORMULATION; PRODUCT; AND USE FOR THE TREATMENT OR PREVENTION OF DISEASES AS DEPENDENT MELLITUS DIABETES, ARTHRITIS, OBESITY, DISLIPID
WO2012006298A3 (en) Formulation for co-therapy treatment of diabetes
WO2007109192A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2008136428A1 (en) Nitrogen-containing five-membered heterocyclic compound
IL184554A0 (en) Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
WO2006099941A8 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
MY146969A (en) Dpp iv inhibitor formulations
PL2083809T3 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes for the treatment of depression.
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
IL225198A (en) Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
WO2007109182A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109201A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009068708A3 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
CL2008000303A1 (en) COMPOUNDS DERIVED FROM 1-OXA-3-AZAESPIRO [4.5] DECAN-2-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF A FOOD, OBESITY, DEPRESSION DISORDER.
WO2011163319A3 (en) Activation of amp-protein activated kinase by oxaloacetate compounds
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2010024594A3 (en) Composition for preventing or relieving obesity or diabetes
WO2007075255A3 (en) Mastic gum composition for use as a dietary supplement in humans and animals
WO2006131836A3 (en) Compounds and compositions for use in the prevention and treatment of obesity and related syndromes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09810199

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09810199

Country of ref document: EP

Kind code of ref document: A2